Researchers will determine whether the fur of animal-assistance therapy dogs can become contaminated with hospital-associated infections and test whether low-costinterventions can reduce the risk of microbial transmission between therapy animals and patients with childhood cancer.

Researchers will test specialized filters that may reduce life-threatening transfusion reactions in dogs.

Researchers will investigate the efficacy of a new pain relief option, the transdermal lidocaine patch, for dogs that undergo surgery.

Researchers will investigate how Staphylococcus pseudintermedius, a common cause of bacterial skin and postoperative infections in dogs, forms groups of bacteria that stick to surfaces, such as catheters and orthopedic metal implants, making infections difficult to treat.

By studying how platelets and bacteria interact when dogs with serious infections develop blood poisoning, the research fellow will gain information that will improve treatment.

Researchers will investigate the effectiveness of the drug misoprostol in treating inflammation in horses.

Researchers will build a new reference genome sequence for the domestic horse, which will provide an important tool for mapping genes that cause equine diseases.

Researchers will investigate the link between persistent organic pollutants in the environment and the development of equine metabolic syndrome.

Researchers will identify the gene(s) and underlying mutations that increase risk of recurrent exertional rhabdomyolysis, or tying up, in Thoroughbred and Standardbred horses.

Researchers will evaluate the safety and effectiveness of a vaccine against foal pneumonia caused by the bacterium Rhodococcus equi.